Word

HERCESSI

Status

Pending

Status Code

686

Status Date

Tuesday, September 17, 2024

Serial Number

98358875

Mark Type

3

Filing Date

Tuesday, January 16, 2024

Published for Opposition

Tuesday, September 17, 2024

Trademark Owner History

Accord Biopharma, Inc. - Owner At Publication

Classifications

9 Downloadable computer application software for mobile phones, namely, software for patients and caregivers to exchange, retrieve, view, and analyze medication, healthcare, and wellness information; Downloadable software for managing medical office inventories of pharmaceutical preparations

5 Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of cancer and cancer-related comorbidities in humans

44 Medical services, namely, providing medical information to cancer patients; Providing health information in the area of oncology

The mark consists of a positive-space hexagon with a hexagon-shaped negative space in the center where the positive-space hexagon is divided in half by the negative-space hexagon and two negative-space lines, one negative-space line radiating in a downward curve to the left from the upper left corner of the negative-space hexagon to the outside of the middle left corner of the positive-space hexagon, and one negative-space line radiating in an upward curve to the right from the lower right corner of the negative-space hexagon to the outside of the middle right corner of the positive-space hexagon. The upper half of the positive-space hexagon is orange and the bottom half of the positive-space hexagon is fuchsia. To the right of the hexagon is the word "HERCESSI" in orange stylized font..
The color(s) orange and fuchsia is/are claimed as a feature of the mark.

Trademark Events

Jan 16, 2024

New Application Entered

May 10, 2024

Notice Of Design Search Code E-Mailed

May 10, 2024

New Application Office Supplied Data Entered

Aug 12, 2024

Approved For Pub - Principal Register

Aug 12, 2024

Assigned To Examiner

Aug 28, 2024

Notification Of Notice Of Publication E-Mailed

Sep 17, 2024

Published For Opposition

Sep 17, 2024

Official Gazette Publication Confirmation E-Mailed